De Cristofaro R - Search Results

Year	Number of Results
1982	2
1987	2
1988	8
1989	5
1990	10
1991	10
1992	5
1993	4
1994	4
1995	2
1996	3
1997	1
1998	3
1999	3
2000	7
2001	3
2002	6
2003	4
2004	3
2005	3
2006	5
2007	5
2008	5
2009	14
2010	17
2011	12
2012	5
2013	13
2014	8
2015	6
2016	3
2017	5
2018	7
2019	11
2020	11
2021	15
2022	18
2023	19
2024	6

1

Effect of statin intake on FVIII levels and bleeding outcomes in hypercholesterolemic patients with hemophilia A.

Paciullo F, Momi S, Mancuso ME, Santoro C, Napolitano M, Castaman G, Zanon E, Contino L, De Cristofaro R, Santoro RC, Gresele P. Paciullo F, et al. Among authors: de cristofaro r. Thromb Res. 2024 Apr;236:167-169. doi: 10.1016/j.thromres.2024.02.028. Epub 2024 Mar 2. Thromb Res. 2024. PMID: 38457995 No abstract available.

2

Design organization and clinical processes around patient characteristics: Evidence from a multiple case study of Hemophilia.

Villa S, De Cristofaro R, Di Minno G, Laratro S, Peyvandi F, Pippo L, Villa S, De Belvis AG. Villa S, et al. Among authors: de cristofaro r. Health Serv Manage Res. 2024 Feb 14:9514848241231585. doi: 10.1177/09514848241231585. Online ahead of print. Health Serv Manage Res. 2024. PMID: 38355431

3

The value-based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia.

Cortesi PA, Fornari C, Conti S, Pollio B, Boccalandro E, Buzzi A, Carulli C, Coppola A, De Cristofaro R, Di Minno MND, Dolan G, Ferri Grazzi E, Fornari A, Gualtierotti R, Hermans C, Jiménez-Juste V, Kenet G, Lupi A, Martinoli C, Mansueto MF, Nicolò G, Tagliaferri A, Gringeri A, Molinari AC, Mantovani LG, Castaman G; V.B.H. project group. Cortesi PA, et al. Among authors: de cristofaro r. Haemophilia. 2024 Mar;30(2):437-448. doi: 10.1111/hae.14943. Epub 2024 Feb 5. Haemophilia. 2024. PMID: 38314918

4

Personalized Prophylaxis with myPKFiT^CE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients.

Antonazzo IC, Cortesi PA, Zanon E, Pasca S, Morfini M, Santoro C, De Cristofaro R, Di Minno G, Cozzolino P, Mantovani LG. Antonazzo IC, et al. Among authors: de cristofaro r. Medicina (Kaunas). 2023 Dec 24;60(1):34. doi: 10.3390/medicina60010034. Medicina (Kaunas). 2023. PMID: 38256294 Free PMC article.

5

Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study.

Holme PA, Poulsen LH, Tueckmantel C, Maas Enriquez M, Alvarez Román MT, De Cristofaro R. Holme PA, et al. Among authors: de cristofaro r. Haemophilia. 2024 Mar;30(2):388-394. doi: 10.1111/hae.14930. Epub 2024 Jan 16. Haemophilia. 2024. PMID: 38229269

6

Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study.

Giordano P, Pollio B, Sottilotta G, Biasoli C, Daniele F, De Cristofaro R, Peyvandi F, Villa MR, Castaman G; IDEAL Study Group. Giordano P, et al. Among authors: de cristofaro r. Eur J Haematol. 2024 May;112(5):765-775. doi: 10.1111/ejh.14168. Epub 2024 Jan 15. Eur J Haematol. 2024. PMID: 38223989

7

Von Willebrand factor hyperactivity affects the outcome of lower limb revascularization in subjects with type 2 diabetes mellitus complicated by diabetic foot vasculopathy: An observational pilot study.

Pitocco D, Popolla V, Rizzi A, Lancellotti S, Tartaglione L, Sacco M, Viti L, Mazzotta FA, Iezzi R, Santoliquido A, Caputo S, Flex A, Pontecorvi A, De Cristofaro R. Pitocco D, et al. Among authors: de cristofaro r. J Diabetes Complications. 2024 Jan;38(1):108653. doi: 10.1016/j.jdiacomp.2023.108653. Epub 2023 Nov 25. J Diabetes Complications. 2024. PMID: 38039934

8

Commentary on "Structural analyses of β2-glycoprotein I: is there a circular conformation?".

Lancellotti S, Sacco M, De Cristofaro R. Lancellotti S, et al. Among authors: de cristofaro r. J Thromb Haemost. 2023 Dec;21(12):3354-3356. doi: 10.1016/j.jtha.2023.07.024. J Thromb Haemost. 2023. PMID: 38000852 No abstract available.

9

Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study.

De Luca L, Temporelli PL, Gulizia MM, Gonzini L, Ammaturo TA, Tedesco L, Pede S, Oliva F, Gabrielli D, Colivicchi F, Averna MR; START Investigators. De Luca L, et al. Nutr Metab Cardiovasc Dis. 2023 Dec;33(12):2398-2405. doi: 10.1016/j.numecd.2023.07.036. Epub 2023 Aug 7. Nutr Metab Cardiovasc Dis. 2023. PMID: 37788956

10

Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C.

De Cristofaro R. De Cristofaro R. Mol Ther Nucleic Acids. 2023 Aug 20;33:749. doi: 10.1016/j.omtn.2023.08.004. eCollection 2023 Sep 12. Mol Ther Nucleic Acids. 2023. PMID: 37621411 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

247 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Results by year